Praxis Medica
Sign in
Issue image

More articles from Volume 50, Issue 1, 2021

A new scoring system for Covid-19 in patients on hemodialysis: Modified Early Warning score

Analysis of the occurrence, location and treatment of laryngeal carcinoma recurrence

Orthodontic treatment of a disto-occlusion with and favorable growth pattern

Sensory processing disorders in premature infants

Examination of early adaptation of newborns small for gestational age

Secondary hyperaldosteronism and hypertension

Miloš Mijalković ,
Miloš Mijalković
View authors publications

Search this author on:

PubMed | Google Scholar
Slavica Pajović Orcid logo ,
Slavica Pajović
View authors publications

Search this author on:

PubMed | Google Scholar
Aleksandar Jovanović ,
Aleksandar Jovanović
View authors publications

Search this author on:

PubMed | Google Scholar
Maja Šipić
Maja Šipić
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2020.

Volume 50, Issue 1 (2021)

pp. 51-54;

https://doi.org/10.5937/pramed2102051m

Abstract

Introduction: Arterial hypertension is a major cardiovascular risk factor affecting about 10-40% of the adult population. Secondary endocrine hypertension most often results from excessive aldosterone secretion. Complications related to excessive aldosterone secretion include atrial fibrillation, myocardial infarction, myocardial fibrosis, left ventricular hypertrophy, stroke, and increased cardiovascular mortality. Case report: This report presents a hypotensive woman with hypertensive reactions, newly diagnosed unilateral hyperplasia of the left adrenal gland and secondary hyperaldosteronism. Due to good blood pressure and normalized electrolyte status as a result of antihypertensive drug therapy and absence of damage to target organs, surgical treatment of unilateral adrenal hyperplasia was postponed. Conclusion: In case of midlife and late-life hypertension, it is necessary to consider a cause in the patient's endocrine system. AUTHORS SUMMARY SRPSKI 2021; 50 (1,2) 51-54

Keywords

hyperaldosteronism,

unilateral adrenal hyperplasia,

hypertension

References

1.
Nakamaru R, Yamamoto K, Nozato S, Hongyo K, Nagasawa M, Hagiya H, et al. A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling. Clinical Case Reports. 2019;7(10):1895–9.
2.
Goh BKP, Tan Y, Chang KTE, Eng PHK, Yip SKH, Cheng CWS. Primary Hyperaldosteronism Secondary to Unilateral Adrenal Hyperplasia: an Unusual Cause of Surgically Correctable Hypertension. A review of 30 cases. World Journal of Surgery. 2007;31(1):72–9.
3.
Novakovic T, S. P, Endocrinology KM. 2010;
4.
Lechner B, Lechner K, Heinrich D, Adolf C, Holler F, Schneider H, et al. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. European Journal of Endocrinology. 2019;181(4):R147–53.
5.
Vakkalanka S, Zhao A, Samannodi M. Primary hyperaldosteronism: a case of unilateral adrenal hyperplasia with contralateral incidentaloma. BMJ Case Reports. :bcr2016216209.
6.
Zoran A. Primary hyperaldosteronism: diagnostic proseduere and treatment. 2003;6(7):37–48.
7.
Fathimah M, Gunavathy M, Nadzimah. A Case of Resistant Hypertension Secondary to Primary Aldosteronism. 2014;4(4):61–4.
8.
Catena C. Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment. Archives of Internal Medicine. 2008;168(1):80.
9.
Francis GS, Tang WHW. Should we consider aldosterone as the primary screening target for preventing cardiovascular events?**Editorials published in the Journal of American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. Journal of the American College of Cardiology. 2005;45(8):1249–50.
10.
Sudano I, Beuschlein F, Lüscher TF. Secondary causes of hypertension. ESC CardioMed. 2018. p. 2409–19.
11.
Zhao L, Liu W, Yu X, Li H. A 100-year old patient presented with profound diuretic-induced hypokalemia as first indicator of primary aldosteronism: a case report. 2016;9(6):12361–4.
12.
Wang W, Wei F, Li R, Tian J. A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma. Medicine. 98(43):e17418.
13.
Papadopoulou-Marketou N, Vaidya A, Dluhy R. Hyperaldosteronism.
14.
Rossi GP. Primary Aldosteronism. Secondary Hypertension. 2020. p. 59–78.
15.
Shen H, Xu Z, Li Q. New advances in the diagnosis of primary aldosteronism. Chronic Diseases and Translational Medicine. 2020;6(1):1–5.
16.
Dominguez A, V M, StatPearls GSH. 2020;
17.
Charles L, Triscott J, Dobbs B. Secondary Hypertension: Discovering the Underlying Cause. 2017;96(7):453–61.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref